Decreased slow-wave sleep and increased REM density are a prominent clinical biomarker of depression.40, 41 Most patients classified as ketamine responders had low levels of slow-wave sleep and BDNF at baseline. The gene discussed is BDNF; the disease is major depressive disorder.